Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05564624 · ClinicalTrials.gov registry record · NA
Effect of Fasting-Mimicking Diet on Skin Health
A NA study, sponsored by L-Nutra.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05564624: Completed NA study, sponsored by L-Nutra.
NCT05564624 is a NA study that has completed, run by L-Nutra. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05564624, a NA study, has completed, sponsored by L-Nutra.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This single-center, randomized, controlled clinical trial is being conducted to assess the efficacy on facial skin appearance of the Sponsor's 5-day meal kit when consumed monthly for 3 cycles over the course of 71 days by women with mild to moderate dry fine lines, lack of smoothness, uneven skin tone, and lack of radiance on the face.
Primary Outcome
Clinical grading will be assessed on the indicated location on each subject's face using a modified Griffiths 10-point scale according to the following numerical definitions. Half-point scores may be used as necessary to more accurately describe the skin condition: 1. Skin smoothness (visual), cheeks; 2. Skin smoothness (tactile), cheeks; 3. Dry fine lines, global face; 4. Clarity, global face; 5. Redness, global face; 6. Evenness of skin tone, global face; 7. Radiance, global face; 8. Overall
Interventions
- OTHER Fasting mimicking diet (FMD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
What the finished NCT05564624 record still lists
NCT05564624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Fasting mimicking diet (FMD) is the first listed.
NCT05564624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05564624 about?
NCT05564624 is a clinical study titled "Effect of Fasting-Mimicking Diet on Skin Health". This single-center, randomized, controlled clinical trial is being conducted to assess the efficacy on facial skin appearance of the Sponsor's 5-day meal kit when consumed monthly for 3 cycles over the course of 71 days by women with mild to moderate dry fine lines, lack of smoothness, uneven skin t...
What is the current status of trial NCT05564624?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2022-01-06. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT05564624?
The interventions under investigation include: Fasting mimicking diet (FMD) (OTHER).
Who is sponsoring clinical trial NCT05564624?
This trial is sponsored by L-Nutra, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05564624's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI